NCT03294694 2025-05-31Ribociclib + PDR001 in Breast Cancer and Ovarian CancerDana-Farber Cancer InstitutePhase 1 Terminated33 enrolled
NCT00617188 2017-12-28Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial CancerMasonic Cancer Center, University of MinnesotaPhase 2 Completed26 enrolled 11 charts